[ET Net News Agency, 29 February 2024] CUTIA-B (02487) rose 11% to HK$9.1.
It hits an intra-day high of HK$9.43, and an intra-day low of HK$8.5. The total shares
traded was 105,200, with a value of HK$951,410. The active buy/sell ratio is 65:35, with
net buying turnover of HK$264,144. CHINA INNOVATION MARKET SER accounts for greatest net
responsive buying turnover of HK$9,398, with volume weighted average price of HK$9.11.
HSBC SEC BRO (ASIA) accounts for greatest net responsive selling turnover of HK$54,000,
with volume weighted average price of HK$9. The stock has risen a combined 54.2% over the
past 8 consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 9.100 % Chg +10.98%
High 9.430 Low 8.500
Shares Tr 105,200 Turnover 951,410
10-D SMA 7.016 %H.V 150.847
20-D SMA 6.861 VWAP 9.044
50-D SMA 7.803 RSI14 65.837
-----------------------------------
Status: Active buy/sell ratio is 65:35, with net buying turnover of HK$264,144, rising a
combined 54.2% over the past 8 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
CUTIA-B (02487) 9.10 +10.98
HUTCHMED (00013) 24.15 +1.90
GENSCRIPT BIO (01548) 15.96 Unchanged
INNOVENT BIO (01801) 42.80 +1.78
EVEREST MED-B (01952) 22.00 +1.85
WUXI BIO (02269) 18.60 +0.76
BEIGENE (06160) 106.40 +2.01
CANSINOBIO (06185) 18.22 +2.71
ZAI LAB (09688) 17.42 +0.35
REMEGEN (09995) 22.30 -1.11
---------------------------------------------
(ed)